+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
U.S. Allergy Diagnostics & Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug, & Other Allergens), By Test Type, And Segment Forecasts, 2025 - 2030- Product Image
U.S. Allergy Diagnostics & Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug, & Other Allergens), By Test Type, And Segment Forecasts, 2025 - 2030- Product Image
New

U.S. Allergy Diagnostics & Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug, & Other Allergens), By Test Type, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 80 Pages
  • June 2025
  • Region: United States
  • Grand View Research
  • ID: 6111310
Description Jump to:

Market Size & Trends

The U.S. allergy diagnostics & therapeutics market size was valued at USD 10.86 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2030. The market is driven by the increasing prevalence of allergies among the population, and environmental factors such as increased pollution and lifestyle changes boost the demand for advanced solutions. The U.S. allergy diagnostics & therapeutics industry has witnessed a shift toward precision diagnostics. This evolution is fueled by groundbreaking innovations in molecular allergology and the widespread adoption of digital health tools.

Companies are actively expanding their allergy test portfolios, focusing on multiplex assays that enable the simultaneous detection of numerous allergens from a single patient sample. Furthermore, these diagnostic platforms are increasingly designed for seamless integration with Electronic Health Records (EHRs), a critical advancement that facilitates comprehensive patient data management and enhances clinical decision-making.

The industry is characterized by a high degree of innovation driven by ongoing research, technological advancements, and the development of more effective diagnostics and treatment options. In April 2025, Beckman Coulter Life Sciences announced the launch of its Next-Generation Basophil Activation Test (BAT). It is only for research purposes to expedite and improve allergy research.

The U.S. allergy diagnostics & therapeutics industry is also characterized by many new launches, strategic collaborations, and acquisitions among key players, emphasizing enhancing diagnostic accuracy and therapeutic efficacy. In January 2024, Inimmune Corporation and Intrommune Therapeutics announced a strategic partnership to develop a groundbreaking oral mucosal immunotherapy for peanut allergy.

U.S. Allergy Diagnostics & Therapeutics Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the U.S. allergy diagnostics & therapeutics market report based on type, allergen type, test type.

Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Diagnostics
  • Instruments
  • Consumables
  • Services
  • Therapeutics
  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anti-cholinergic
  • Immuno-modulators
  • Epinephrine
  • Immunotherapy

Allergen Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Food
  • Dairy Products
  • Poultry Product
  • Tree Nuts
  • Peanuts
  • Shellfish
  • Wheat
  • Soys
  • Other Food Allergens
  • Inhaled
  • Drug
  • Other Allergens

Test Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • In vivo test
  • Skin Prick Test
  • Intradermal Test
  • Patch Test
  • In vitro test

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Allergen Type
1.2.3. Test Type
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test outlook
2.2.2. Allergen Type outlook
2.2.3. Test Type outlook
2.3. Competitive Insights
Chapter 3. U.S. Allergy Diagnostics & Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Allergy Diagnostics & Therapeutics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. U.S. Allergy Diagnostics & Therapeutics Market: Pipeline Analysis
Chapter 4. U.S. Allergy Diagnostics & Therapeutics Market: Type Estimates & Trend Analysis
4.1. Type Segment Dashboard
4.2. U.S. Allergy Diagnostics & Therapeutics Market: Type Movement Analysis
4.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Type, 2018 To 2030 (USD Billion)
4.4. Diagnostics
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.2. Instruments
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.3. Consumables
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.4. Services
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5. Therapeutics
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.2. Antihistamines
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.3. Decongestants
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.4. Corticosteroids
4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.5. Mast Cell Stabilizers
4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.6. Leukotriene Inhibitors
4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.7. Nasal Anti - Cholinergic
4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.8. Immuno - Modulators
4.5.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.9. Epinephrine
4.5.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.10. Immunotherapy
4.5.10.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Estimates & Trend Analysis
5.1. Allergen Type Segment Dashboard
5.2. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Movement Analysis
5.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, by Allergen Type, 2018 to 2030 (USD Billion)
5.4. Food
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.2. Dairy Products
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.3. Poultry Product
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.4. Tree Nuts
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.5. Peanuts
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.6. Shellfish
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.7. Wheat
5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.8. Soys
5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.9. Other Food Allergens
5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.5. Inhaled
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.6. Drug
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.7. Other Allergens
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Estimates & Trend Analysis
6.1. Test Type Segment Dashboard
6.2. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Movement Analysis
6.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Test Type, 2018 to 2030 (USD Billion)
6.4. In vivo test
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
6.4.2. Skin Prick Test
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
6.4.3. Intradermal Test
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
6.4.4. Patch Test
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
6.5. In vitro test
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
7.4.1. Thermo Fischer Scientific Inc.
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Type benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Stallergenes Greer
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Type benchmarking
7.4.2.4. Strategic initiatives
7.4.3. HYCOR Biomedical
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Type benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Minaris Medical America, Inc.
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Type benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Omega Diagnostics Ltd
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Type benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Lincoln Diagnostics, Inc.
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Type benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Danaher Corporation
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Type benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Alcon Inc.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Type benchmarking
7.4.8.4. Strategic initiatives
7.4.9. AbbVie Inc.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Type benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Sanofi
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Type benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Pfizer Inc.
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Type benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Merck & Co., Inc.
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Type benchmarking
7.4.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. allergy diagnostics & therapeutics market, by type, 2018 - 2030 (USD Billion)
Table 3 U.S. allergy diagnostics & therapeutics market, by allergen type, 2018 - 2030 (USD Billion)
Table 4 U.S. allergy diagnostics & therapeutics market, by test type, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. Allergy Diagnostics & Therapeutics market: market outlook
Fig. 10 U.S. Allergy Diagnostics & Therapeutics competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. Allergy Diagnostics & Therapeutics market driver impact
Fig. 16 U.S. Allergy Diagnostics & Therapeutics market restraint impact
Fig. 17 U.S. Allergy Diagnostics & Therapeutics market strategic initiatives analysis
Fig. 18 U.S. Allergy Diagnostics & Therapeutics market: type movement analysis
Fig. 19 U.S. Allergy Diagnostics & Therapeutics market: type outlook and key takeaways
Fig. 20 Diagnostics market estimates and forecast, 2018 - 2030
Fig. 21 Instrument market estimates and forecast, 2018 - 2030
Fig. 22 Consumable market estimates and forecast, 2018 - 2030
Fig. 23 Service market estimates and forecast, 2018 - 2030
Fig. 24 Therapeutics market estimates and forecast, 2018 - 2030
Fig. 25 Antihistamines market estimates and forecast, 2018 - 2030
Fig. 26 Decongestants market estimates and forecast, 2018 - 2030
Fig. 27 Corticosteroids market estimates and forecast, 2018 - 2030
Fig. 28 Mast cell stabilizers market estimates and forecast, 2018 - 2030
Fig. 29 Leukotriene inhibitors market estimates and forecast, 2018 - 2030
Fig. 30 Nasal anti - cholinergic market estimates and forecast, 2018 - 2030
Fig. 31 Immuno-modulators market estimates and forecast, 2018 - 2030
Fig. 32 Epinephrine market estimates and forecast, 2018 - 2030
Fig. 33 Immunotherapy market estimates and forecast, 2018 - 2030
Fig. 34 U.S. Allergy Diagnostics & Therapeutics market: allergen type movement analysis
Fig. 35 U.S. Allergy Diagnostics & Therapeutics market: allergen type outlook and key takeaways
Fig. 36 Food market estimates and forecasts, 2018 - 2030
Fig. 37 Dairy products market estimates and forecasts,2018 - 2030
Fig. 38 Poultry products market estimates and forecasts,2018- 2030
Fig. 39 Tree nuts market estimates and forecasts,2018 - 2030
Fig. 40 Peanuts market estimates and forecasts,2018 - 2030
Fig. 41 Shellfish market estimates and forecasts,2018 - 2030
Fig. 42 Soys market estimates and forecasts,2018 - 2030
Fig. 43 Other food allergens market estimates and forecasts,2018 - 2030
Fig. 44 Inhaled market estimates and forecasts,2018 - 2030
Fig. 45 Drug market estimates and forecasts,2018 - 2030
Fig. 46 Other allergens market estimates and forecasts,2018 - 2030
Fig. 47 U.S. Allergy Diagnostics & Therapeutics market: test type movement analysis
Fig. 48 U.S. Allergy Diagnostics & Therapeutics market: test type outlook and key takeaways
Fig. 49 North America market estimates and forecasts, 2018 - 2030
Fig. 50 In vivo test market estimates and forecasts, 2018 - 2030
Fig. 51 Skin prick test market estimates and forecasts, 2018 - 2030
Fig. 52 Intradermal market estimates and forecasts, 2018 - 2030
Fig. 53 Patch test market estimates and forecasts,2018 - 2030
Fig. 54 In vitro test market estimates and forecasts,2018 - 2030

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Stallergenes Greer
  • HYCOR Biomedical
  • Minaris Medical America, Inc.
  • Omega Diagnostics Ltd
  • Lincoln Diagnostics, Inc.
  • Danaher Corporation
  • Alcon Inc.
  • AbbVie Inc.
  • Sanofi
  • Pfizer Inc.
  • Merck & Co., Inc.

Table Information

Report AttributeDetails
No. of Pages80
PublishedJune 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 10.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.13 Billion
Compound Annual Growth Rate6.8%
Regions CoveredUnited States
No. of Companies Mentioned12

Related Topics

Related Reports

Allergy Diagnostics Market Size, Share & Trends Analysis Report By Products And Services (Instruments, Consumables), By Allergen (Food, Inhaled, Drugs), By Test Type (In Vivo Test, In Vitro Test), By End Use (Hospital & Clinics), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Allergy Diagnostics Market Size, Share & Trends Analysis Report By Products And Services (Instruments, Consumables), By Allergen (Food, Inhaled, Drugs), By Test Type (In Vivo Test, In Vitro Test), By End Use (Hospital & Clinics), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 320 Pages
  • Global
From
Pediatric Allergy Diagnostics Market Size, Share and Trends Analysis Report by Product (Instruments, Consumables), Allergen (Food, Inhaled, Drug), Test (in Vivo Test, in Vitro Test), and Region 2024-2030 - Product Image

Pediatric Allergy Diagnostics Market Size, Share and Trends Analysis Report by Product (Instruments, Consumables), Allergen (Food, Inhaled, Drug), Test (in Vivo Test, in Vitro Test), and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Food Allergy Treatment Market Size, Share & Trends Analysis Report By Allergen Type (Dairy Products, Peanuts, Poultry Products), By Drug Type (Immunotherapy, Antihistamines), By Route of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Food Allergy Treatment Market Size, Share & Trends Analysis Report By Allergen Type (Dairy Products, Peanuts, Poultry Products), By Drug Type (Immunotherapy, Antihistamines), By Route of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Allergy Diagnostics and Therapeutics Market Size, Share & Trends Analysis Report by Type (Diagnostics, Therapeutics), Allergen Type (Food, Inhaled, Drug), Test Type, Region, and Segment Forecasts, 2024-2030 - Product Image

Allergy Diagnostics and Therapeutics Market Size, Share & Trends Analysis Report by Type (Diagnostics, Therapeutics), Allergen Type (Food, Inhaled, Drug), Test Type, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Pediatric Allergy Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032 - Product Image

Pediatric Allergy Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032

  • Report
  • 176 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.